We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$525B
AUM Growth
+$91.7B
Cap. Flow
+$84.3B
Cap. Flow %
16.06%
Top 10 Hldgs %
21.31%
Holding
3,738
New
263
Increased
2,391
Reduced
822
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Financials 10.66%
3 Healthcare 9.68%
4 Consumer Discretionary 8.35%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACET icon
3551
Adicet Bio
ACET
$77.6M
$36.5K ﹤0.01%
1,885
-7,495
-80% -$201K
TVGN icon
3552
Tevogen Bio Holdings
TVGN
$25.1M
$35.9K ﹤0.01%
+992
New +$64.6K
ZDGE icon
3553
Zedge
ZDGE
$38.3M
$34.5K ﹤0.01%
11,319
NEOV icon
3554
NeoVolta
NEOV
$108M
$34.2K ﹤0.01%
12,964
KRMD icon
3555
KORU Medical Systems
KRMD
$187M
$34K ﹤0.01%
12,813
-79,915
-86% -$183K
SUP
3556
DELISTED
Superior Industries International
SUP
$33.6K ﹤0.01%
10,350
STI icon
3557
Solidion Technology
STI
$51.5M
$33.3K ﹤0.01%
+1,210
New +$123K
FARM
3558
DELISTED
Farmer Brothers
FARM
$31.6K ﹤0.01%
11,781
BDSX icon
3559
Biodesix
BDSX
$211M
$31.6K ﹤0.01%
1,031
OSS icon
3560
One Stop Systems
OSS
$269M
$31.1K ﹤0.01%
12,911
LYRA
3561
DELISTED
LYRA THERAPEUTICS INC
LYRA
$30.9K ﹤0.01%
+2,232
New +$252K
LPTH icon
3562
Lightpath Technologies
LPTH
$590M
$30.5K ﹤0.01%
24,173
CTMX icon
3563
CytomX Therapeutics
CTMX
$690M
$30.3K ﹤0.01%
24,817
ALLK
3564
DELISTED
Allakos
ALLK
$29.8K ﹤0.01%
29,756
-151,975
-84% -$181K
ASXC
3565
DELISTED
Asensus Surgical, Inc.
ASXC
$29.5K ﹤0.01%
88,725
CRVS icon
3566
Corvus Pharmaceuticals
CRVS
$1.1B
$28.5K ﹤0.01%
15,668
AREC icon
3567
American Resources Corp
AREC
$183M
$28.4K ﹤0.01%
38,831
+71
+0.2% +$86
ANIX icon
3568
Anixa Biosciences
ANIX
$118M
$28.3K ﹤0.01%
12,785
IMUX icon
3569
Immunic
IMUX
$178M
$27.9K ﹤0.01%
2,510
+10
+0.4% +$124
USIO icon
3570
Usio Inc
USIO
$54.4M
$27.2K ﹤0.01%
17,787
PSNL icon
3571
Personalis
PSNL
$1.25B
$26.8K ﹤0.01%
22,941
CLSD
3572
DELISTED
Clearside Biomedical
CLSD
$26.3K ﹤0.01%
1,348
CURI icon
3573
CuriosityStream
CURI
$148M
$26.3K ﹤0.01%
23,041
PDYN icon
3574
Palladyne AI
PDYN
$228M
$25.8K ﹤0.01%
16,115
YHGJ icon
3575
Yunhong Green CTI Ltd
YHGJ
$7.75M
$25.3K ﹤0.01%
2,021

Similar funds

Charles Schwab's Q2 2024 Portfolio in Review

As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.

  • Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
  • Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
  • Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
  • Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
  • Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
  • Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
  • Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.

Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.